Oct 29, 2026 earnings call — Q3 results and Rapak divestiture
TriMas reported third quarter net sales increased 7.7% to $178.7 million.
Revenue $0.2B (est $0.2B) · EPS $0.50 (est $0.48)
Key quotes
"Our previously announced cost reduction actions totaling $10.5 million in expected 2026 savings and $16 million on an annualized basis continue to proceed as planned."
"Turning to our portfolio initiatives, we recently signed an agreement to divest Rapak, our flexible bag-in-box business, to Ringmetall, a global packaging solutions company."
"In fact, two key machines that experienced significant downtime in the third quarter are now operating near expected levels."
Analyst Q&A 3
M&A focus and packaging cost impact
Q (Ken Newman · KeyBanc): They asked for color on the M&A pipeline and capital allocation priorities, and whether life sciences remains a key focus. They also asked to quantify the negative price/cost impacts in the Packaging segment this quarter.
A: Management said they remain focused on areas that meet their strategic criteria, including parts of life sciences and packaging, and that the M&A process is active but disciplined with nothing new to add. On Packaging, they said less of the earlier 100 basis points headwind came through in the third quarter because resin prices did not fall as quickly as forecast. They expect to recover those costs over time through contract adjustments, especially if the Middle East conflict stabilizes, but the recovery did not happen in Q3.
"Less of those 100 basis points came through in the third quarter." — Paul Swart (CFO)
Sale space, seasonality, and free cash flow
Q (Hamed Khorsand · BWS Financial): He asked how much manufacturing space the sale frees up and whether they will use that space for expansion. He also asked if seasonality changes for Packaging in Q4 and Q1, and when free cash flow might recover.
A: They said the sold product lines are made in specific buildings that will go with the sale, so it is mainly product pruning rather than freeing large retained space. They said the flexible business was small and not core, and that Q4 and Q1 are the lower quarters, with Q4 typically the lowest revenue quarter and Q1 a bit stronger. On free cash flow, they said it ebbs through the year with Q1 heavy on inventory build and Q4 should be the best free cash flow quarter as inventory and receivables are liquidated.
"Q4 typically is the lowest quarter historically from a revenue perspective." — Paul Swart (CFO)
Rapak sale effect and Norris margin recovery timing
Q (Ken Newman · KeyBanc): He asked how the Rapak divestiture will affect Packaging segment margins into 2027. He also asked whether Norris Cylinder margins will improve sequentially in Q4 or if recovery is mainly a 2027 event, and about any 2027 margin outlook.
A: They declined to disclose specific margin impact but said the Rapak business has margins below average and therefore will mix the company margin profile; they noted Rapak is a $20 million annual business. For Norris Cylinder, they said you should expect margin improvement in Q4 versus Q3 because key machines are now up and running, but full recovery will take time and requires sustained machine uptime. On 2027 outlook, they said operational efforts are gaining traction and they will spread that model into 2027, and demand looks pretty stable, but they would not give specific 2027 guidance.
"At the moment, we are not going to disclose the specific impact relative to it, but what we did provide clarity around is that the margins of that business are below average, so it will mix us up going forward." — Paul Swart (CFO)